RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00035024.xml
PDF herunterladen
Thromb Haemost 2000; 84(05): 920-921
DOI: 10.1055/s-0037-4140
DOI: 10.1055/s-0037-4140
Letters to the Editor
Improving Methods to Assess Therapeutic Quality Control of Treatment with Oral Anticoagulants
Autor*innen
Weitere Informationen
Publikationsverlauf
Received
15. März 2000
Accpeted after revision
30. Mai 2000
Publikationsdatum:
13. Dezember 2017 (online)
-
References
- 1 Hirsh J, Dalen JE, Anderson DR, Poller L, Bussey H, Ansell J, Deykin D, Brandt JT. Oral anticoagulants. Mechanisms of action, clinical effectiveness and optimal therapeutic range. Chest 1998; 114: 445S-69S.
- 2 Duxbury BmcD. Therapeutic control of anticoagulant treatment. Br Med J 1982; 284: 702-4.
- 3 Rosendaal FR, Cannegieter SC, Van der Meer FJM, Vandenbroucke JP, Briët E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 1993; 69: 236-9.
- 4 Hutten BA, Prins MH, Redekop WK, Tijssen JGP, Heisterkamp SH, Büller HR. Comparison of three methods to assess therapeutic quality control of treatment with vitamin K antagonists. Thromb Haemost 1999; 82: 1260-3.
- 5 Marco F, Lopez MDuarte, Sedano C, Bermudez A, Perez RMontes, Carreter E, Fernández EFontecha, Ontañon A, Conde E, Zubizarreta A. Computerised oral anticoagulant dosage: a prospective randomized study of 5568 tests. Blood 1999; 94 (suppl 1, part 2): 109b.